| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +4.22% | -2.92% | +7.14% | +7.14% | — |
| 14d | 1 | +100.00% | +4.39% | -3.58% | +7.97% | +7.97% | — |
| 30d | 1 | +0.00% | -9.21% | -1.65% | -7.56% | -7.56% | — |
| 60d | 1 | +0.00% | -34.21% | +1.21% | -35.42% | -35.42% | — |
| 90d | 1 | +0.00% | -35.53% | +6.46% | -41.99% | -41.99% | — |
| 180d | 1 | +0.00% | -49.12% | +16.85% | -65.97% | -65.97% | — |
| 1y | 1 | +0.00% | -78.03% | +28.08% | -106.11% | -106.11% | — |
| 2y | 1 | +0.00% | -97.25% | +52.05% | -149.30% | -149.30% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ENVB ENVERIC BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 18,518 | — | — | 26,423 | Jun 1, 2026 | Jun 3, 2026 ↗ | View → |
| ENVB ENVERIC BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 7,633 | — | — | 7,904 | Dec 23, 2025 | Dec 30, 2025 ↗ | View → |
| ENVB ENVERIC BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 47,733 | — | — | 48,733 | Oct 9, 2024 | Oct 11, 2024 ↗ | View → |
| ENVB ENVERIC BIOSCIENCES, INC. | PURCHASE | 1,000 | $2.14 | $2.1K | 1,000 | Sep 15, 2023 | Sep 19, 2023 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | SALE SVP, CHIEF BUSINESS OFFICER | 3,779 | $8.36 | $31.6K | 429,783 | Nov 19, 2021 | Nov 23, 2021 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | SALE SVP, Chief Business Officer | 3,779 | $14.05 | $53.1K | 433,562 | Aug 20, 2021 | Aug 24, 2021 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | SALE SVP, Chief Business Officer | 3,779 | $17.80 | $67.3K | 437,341 | May 20, 2021 | May 24, 2021 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | SALE SVP, Chief Business Officer | 26,961 | $18.79 | $506.6K | 439,719 | Feb 20, 2021 | Feb 23, 2021 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 466,680 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | SALE SVP, Chief Comm Ops Officer | 4,214 | $17.21 | $72.5K | 401,680 | Nov 20, 2020 | Nov 24, 2020 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | SALE SVP, Chief Comm Ops Officer | 4,214 | $18.22 | $76.8K | 405,894 | Aug 20, 2020 | Aug 24, 2020 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | SALE SVP, Chief Comm Ops Officer | 4,214 | $26.67 | $112.4K | 410,108 | May 20, 2020 | May 22, 2020 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | SALE SVP, Chief Comm Ops Officer | 24,392 | $25.90 | $631.8K | 412,920 | Feb 20, 2020 | Feb 24, 2020 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 383,312 | Feb 3, 2020 | Feb 5, 2020 ↗ | View → |
| TBPH THERAVANCE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 54,000 | — | — | 437,312 | Feb 3, 2020 | Feb 5, 2020 ↗ | View → |